Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 219 | 53 | 150 |
| Samples | 206 | 53 | 148 |
| Peptides | 164 | 36 | 122 |
Function
HOXD9 · Homeobox D9
This gene belongs to the homeobox family of genes. The homeobox genes encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar homeobox gene clusters, HOXA, HOXB, HOXC and HOXD, located on different chromosomes, consisting of 9 to 11 genes arranged in tandem. This gene is one of several homeobox HOXD genes located at 2q31-2q37 chromosome regions. Deletions that removed the entire HOXD gene cluster or 5' end of this cluster have been associated with severe limb and genital abnormalities. The exact role of this gene has not been determined. [provided by RefSeq, Jul 2008].
Isoforms & Proteins
1 transcript · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
| Transcript | UniProt | Mutations | Peptides |
|---|---|---|---|
| ENST00000249499 | P28356 | 219 | 164 |
Gene Properties
Recurrent Mutations
All 164 amino-acid changes on canonical ENST00000249499 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in HOXD9 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in HOXD9 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| Chronic Myelogenous Leukemia | 2/25 8% | 0/0 0% |
| T-Lymphoblastic Leukemia | 1/40 2% | 0/0 0% |
| Endometrial Carcinoma | 5/42 12% | 8/612 1% |
| Gastric Carcinoma | 6/74 8% | 24/1809 1% |
| Non-Small Cell Lung Carcinoma | 5/304 2% | 16/1390 1% |
| Acute Myeloid Leukemia | 1/90 1% | 0/0 0% |
| Squamous Cell Lung Carcinoma | 1/57 2% | 8/810 1% |
| Germ Cell Tumour | 1/25 4% | 1/169 1% |
| Melanoma | 3/210 1% | 14/1899 1% |
| Hodgkins Lymphoma | 1/16 6% | 0/122 0% |
| Colorectal Carcinoma | 6/143 4% | 17/3239 1% |
| Neuroendocrine Tumour | 2/154 1% | 3/577 1% |
| Cervical Carcinoma | 2/35 6% | 1/422 0% |
| Esophageal Carcinoma | 0/23 0% | 5/769 1% |
| Head and Neck Carcinoma | 4/85 5% | 5/1574 0% |
| Small Cell Lung Carcinoma | 0/9 0% | 4/752 1% |
| Thyroid Gland Carcinoma | 2/45 4% | 4/1592 0% |
| Other Solid Cancers | 0/94 0% | 6/1515 0% |
| B-Cell Non-Hodgkins Lymphoma | 4/88 5% | 5/2534 0% |
| Esophageal Squamous Cell Carcinoma | 0/51 0% | 8/2550 0% |
| Other Sarcomas | 1/69 1% | 1/699 0% |
| Hepatocellular Carcinoma | 0/46 0% | 5/2210 0% |
| Medulloblastoma | 0/0 0% | 1/450 0% |
| Non-Cancerous | 0/104 0% | 2/830 0% |
| Bladder Carcinoma | 0/58 0% | 2/956 0% |
| Prostate Carcinoma | 0/13 0% | 4/2105 0% |
| Pancreatic Carcinoma | 1/89 1% | 2/1611 0% |
| Ovarian Carcinoma | 2/109 2% | 0/998 0% |
| Neuroblastoma | 2/87 2% | 0/1331 0% |
| Glioma | 0/52 0% | 3/2127 0% |
Mutation Distribution
Where HOXD9 is mutated · all tissues, split by cell line vs tissue
How many mutations in HOXD9 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 44 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 219 mutations in HOXD9
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|